A carregar...
PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases
The phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) signaling pathway has been implicated as a cancer target. Big pharma players and small companies have been developing small molecule inhibitors of PI3K and/or mTOR since the 1990s. Although four inhibitors have been approv...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6888641/ https://ncbi.nlm.nih.gov/pubmed/31752127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20225792 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|